HomeCompareEFLVF vs JNJ

EFLVF vs JNJ: Dividend Comparison 2026

EFLVF yields 55.71% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EFLVF wins by $496.5K in total portfolio value
10 years
EFLVF
EFLVF
● Live price
55.71%
Share price
$3.59
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$526.7K
Annual income
$116,253.18
Full EFLVF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — EFLVF vs JNJ

📍 EFLVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEFLVFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EFLVF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EFLVF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EFLVF
Annual income on $10K today (after 15% tax)
$4,735.38/yr
After 10yr DRIP, annual income (after tax)
$98,815.20/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, EFLVF beats the other by $94,829.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EFLVF + JNJ for your $10,000?

EFLVF: 50%JNJ: 50%
100% JNJ50/50100% EFLVF
Portfolio after 10yr
$278.5K
Annual income
$60,471.29/yr
Blended yield
21.71%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EFLVF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
8.3
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EFLVF buys
0
JNJ buys
0
No recent congressional trades found for EFLVF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEFLVFJNJ
Forward yield55.71%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$526.7K$30.3K
Annual income after 10y$116,253.18$4,689.40
Total dividends collected$430.4K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: EFLVF vs JNJ ($10,000, DRIP)

YearEFLVF PortfolioEFLVF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$16,271$5,571.03$10,592$272.30+$5.7KEFLVF
2$25,882$8,471.63$11,289$357.73+$14.6KEFLVF
3$40,287$12,593.88$12,123$472.89+$28.2KEFLVF
4$61,428$18,321.10$13,141$629.86+$48.3KEFLVF
5$91,836$26,107.78$14,408$846.81+$77.4KEFLVF
6$134,743$36,477.96$16,021$1,151.60+$118.7KEFLVF
7$194,194$50,019.36$18,122$1,588.22+$176.1KEFLVF
8$275,160$67,372.86$20,930$2,228.20+$254.2KEFLVF
9$383,639$89,217.78$24,792$3,191.91+$358.8KEFLVF
10$526,747$116,253.18$30,274$4,689.40+$496.5KEFLVF

EFLVF vs JNJ: Complete Analysis 2026

EFLVFStock

Electrovaya Inc., together with its subsidiaries, engages in the designing, developing, and manufacturing lithium-ion advanced battery and battery systems in North America. It offers lithium-ion batteries and systems for materials handling electric vehicles, including forklifts and automated guided vehicles, as well as battery chargers to charge the batteries; electromotive power products for electric trucks, electric buses, and other transportation applications; industrial products for energy storage; and power solutions, such as building systems for third parties. The company was formerly known as Electrofuel Inc. and changed its name to Electrovaya Inc. in March 2002. Electrovaya Inc. was incorporated in 1996 and is headquartered in Mississauga, Canada.

Full EFLVF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this EFLVF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EFLVF vs SCHDEFLVF vs JEPIEFLVF vs OEFLVF vs KOEFLVF vs MAINEFLVF vs ABBVEFLVF vs MRKEFLVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.